Researchers in Japan have developed a non-invasive stool-based DNA test that identifies microbial signatures linked to ...

Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data.

This upgraded space significantly increases throughput, efficiency, and reliability within an already well‑established microbial limits testing program. With the added capacity, the team can now ...

Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been ...

One of the most stubborn paradoxes in modern drug discovery is that the majority of Earth’s microorganisms refuse to grow in ...

Microbial testing laboratories often face challenges such as genetic drift, variability in results, and the need for extensive preparation. These issues can lead to inconsistent results and increased ...

Ensuring pharmaceutical safety and efficacy hinges on rigorous quality control (QC). By identifying potential microbial contaminants early in drug development and production, microbial QC tests ...

Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...

Boost ROI through rapid molecular and AI-enabled diagnostics, automated workflows, portfolio expansion, public-health partnerships, and geographic growth in underserved markets.Dublin, Sept. (GLOBE ...

ASTM has worked diligently to develop a microbial barrier test for terminally sterilized packaging. In 1997, the European Committee for Standardization (CEN) and International Organization for ...